FGF-BP Activators
FGF-BP activators refer to a range of chemical agents designed to modulate the activity of the Fibroblast Growth Factor-Binding Protein (FGF-BP). FGF-BP is a protein that plays a critical role in the regulation of fibroblast growth factors (FGFs), which are key players in many biological processes, including cell growth, development, and angiogenesis. FGF-BP binds to FGFs and can potentiate their biological activity by presenting them to their cognate receptors on the cell surface, thereby influencing signal transduction pathways that control cell proliferation and differentiation.
The activation of FGF-BP by these agents can occur through direct or indirect mechanisms. Direct activators would bind specifically to FGF-BP, altering its conformation in a way that enhances its affinity for FGFs or its ability to interact with FGF receptors. This could lead to an increased potency of FGF-mediated signaling. Such activators might mimic structural elements of FGFs or interact with key domains on the FGF-BP that are involved in the stabilization of FGF/FGF-BP complexes. Indirect activators of FGF-BP may not interact with the protein directly but rather affect the expression levels, stability, or post-translational modifications of FGF-BP. For instance, they could upregulate the transcription of the FGF-BP gene or enhance the translation process, leading to an accumulation of functional FGF-BP in the cell. They might also inhibit the degradation pathways of FGF-BP, resulting in prolonged activity of the protein. Additionally, indirect activators could modulate the signaling pathways that either control the expression of FGF-BP or modulate its activity post-translationally.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC). PKC signals down a cascade to activate MAPK/ERK pathway, which can enhance the release of FGF-BP from cells, therefore elevating FGF-BP's functional activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels. Elevated cAMP levels lead to Protein Kinase A (PKA) activation, which can stimulate the release of FGF-BP, enhancing its functional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific PDE inhibitor that leads to increased cAMP levels. The enhanced cAMP levels activate PKA, which can stimulate the release of FGF-BP, thereby enhancing its functional activity. | ||||||
Heparin | 9005-49-6 | sc-507344 | 25 mg | $119.00 | 1 | |
Heparin is known to bind FGFs and prevent their degradation. This can enhance the availability of FGFs for FGF-BP to bind and transport to FGFRs, enhancing the functional activity of FGF-BP. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Suramin is a polysulphonated naphthylurea that binds growth factors such as FGFs. This can increase the availability of FGFs for FGF-BP to bind and transport to FGFRs, enhancing the functional activity of FGF-BP. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $33.00 $131.00 | 3 | |
PI-103 is a PI3K inhibitor. It can decrease PI3K/Akt pathway signaling, leading to an increase in FGF-BP release from cells, enhancing its functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. It can decrease PI3K/Akt pathway signaling, leading to an increase in FGF-BP release from cells, thereby enhancing its functional activity. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
BAY 43-9006 is a Raf kinase inhibitor. It can inhibit Raf/MEK/ERK pathway, leading to an increase in FGF-BP release from cells, thereby enhancing its functional activity. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $343.00 $1642.00 | 20 | |
Calphostin C is a specific inhibitor of PKC. By inhibiting PKC, it can stimulate the release of FGF-BP from cells, thereby enhancing its functional activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor. It can inhibit the MAPK/ERK pathway, leading to an increase in FGF-BP release from cells, thereby enhancing its functional activity. | ||||||